Target Price | $147.90 |
Price | $145.03 |
Potential |
1.98%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Insmed Incorporated 2026 .
The average Insmed Incorporated target price is $147.90.
This is
1.98%
register free of charge
$252.00
73.76%
register free of charge
$111.10
23.40%
register free of charge
|
|
A rating was issued by 26 analysts: 24 Analysts recommend Insmed Incorporated to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insmed Incorporated stock has an average upside potential 2026 of
1.98%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 363.71 | 479.90 |
19.17% | 31.95% | |
EBITDA Margin | -214.87% | -206.06% |
2.97% | 4.10% | |
Net Margin | -251.24% | -246.15% |
2.30% | 2.02% |
21 Analysts have issued a sales forecast Insmed Incorporated 2025 . The average Insmed Incorporated sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Insmed Incorporated EBITDA forecast 2025. The average Insmed Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Insmed Incorporated Analysts have issued a net profit forecast 2025. The average Insmed Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.57 | -5.60 |
4.31% | 0.54% | |
P/E | negative | |
EV/Sales | 61.07 |
22 Analysts have issued a Insmed Incorporated forecast for earnings per share. The average Insmed Incorporated EPS is
This results in the following potential growth metrics and future valuations:
Insmed Incorporated...
Analyst | Rating | Action | Date |
---|---|---|---|
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
William Blair |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
Analyst Rating | Date |
---|---|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Sep 03 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 21 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 20 2025 |
Locked
William Blair:
Locked
➜
Locked
|
Aug 20 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 14 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Aug 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.